ANTI-ITCH suspension (10 ml)

Suspension from light yellow to dark yellow colour, which may separate during storage, with sediment.

1 ml of the product contains the following active substance:

- triamcinolone – 1,0 mg.

Excipients: pyridoxine hydrochloride, riboflavin, nicotinamide, methionine, succinic acid, xanthan gum, polysorbate 80, sodium benzoate, sucralose, glycerol, flavouring agent, purified water.

ATCvet classification code: QD07АВ Glucocorticoids, moderately potent (group II). QD07AB09 Triamcinolone.

The product, due to the presence of a highly effective anti-inflammatory component, B-group vitamins, methionine and succinic acid, exerts a complex effect on irritated skin and rapidly relieves unpleasant sensations of dryness, pruritus and discomfort in animals. Triamcinolone is a synthetic glucocorticoid with pronounced anti-inflammatory, desensitizing and anti-edematous effects, mediated by inhibition of the release of inflammatory mediators, including prostaglandins, which potentiate the inflammatory process. B-group vitamins, succinic acid and methionine improve metabolism and tissue trophism, promote acceleration of healing processes, reduce the inflammatory response and exert a complex positive effect on the condition of the skin and hair coat. According to the degree of impact on the body of warm-blooded animals, the product is classified as a low-hazard substance.

Treatment of dogs and cats with inflammatory and allergic skin diseases (atopic, allergic, contact dermatitis, eczema, diffuse neurodermatitis, pruritus, alopecia, reactions to insect bites)

The product is administered to the animal in the morning orally with a small amount of feed or administered forcibly using a dosing syringe once daily in daily doses indicated in Table 1.

Shake the vial thoroughly before use.

Daily doses of ANTI-ITCH suspension for dogs and cats

For the first 4 days, the product is administered at the dosage indicated in Table 1; for the next 6–8 days, administer a dose equal to ½ of the indicated dose; for the last 1–2 days, administer ¼ of the indicated dose.

The course of treatment may be extended based on the decision of the attending veterinarian.

Avoid missing doses of the product, as this may lead to a reduction in its effectiveness.

Do not use in animals with hypersensitivity to the active substance or to any of the excipients.

Do not use in animals suffering from diabetes mellitus or viral infections.

Do not use the product in pregnant or lactating females, or in puppies and kittens under 8 weeks of age.

The product is not intended for use in food-producing animals.

When the product is used for the first time, in individual animals increased salivation may occur, which resolves quickly and does not require medical treatment.

The product is not recommended for concomitant use with other medicinal products containing corticosteroid hormones.

The product has no cumulative properties.

The product does not exhibit delayed adverse effects such as embryotoxic, teratogenic or mutagenic effects.

Vials made of neutral glass (types NS-1, NS-2, USP-1), closed with rubber stoppers and sealed with aluminium caps, or polymer vials closed with plastic caps of 10 or 15 ml. A dosing syringe with a volume of 2,0 or 2,5 ml is supplied. Secondary packaging: cardboard box.

Store in a dry, dark place, out of reach of children, at a temperature between 5 and 25 °C.

18 months.

Shelf life after first opening of the vial: 14 days.